Department of Psychiatry, University of Hong Kong, Hong Kong SAR, China.
Sleep. 2011 Jun 1;34(6):807-15. doi: 10.5665/SLEEP.1056.
To evaluate the efficacy and safety of electroacupuncture as an additional treatment for residual insomnia associated with major depressive disorder (MDD).
Randomized, placebo-controlled.
A psychiatric outpatient clinic.
78 Chinese patients with DSM-IV-diagnosed MDD, insomnia complaint, a Hamilton Rating Scale for Depression (HDRS(17)) score ≤ 18, and fixed antidepressant dosage.
Electroacupuncture, minimal acupuncture (superficial needling at non-acupuncture points), or noninvasive placebo acupuncture 3 sessions weekly for 3 weeks.
Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), HDRS(17), 1 week sleep diaries, and 3 day actigraphy were administered at baseline, 1 week post-treatment, and 4 week post-treatment. There was significant group by time interaction in ISI, PSQI, and sleep diary-derived sleep efficiency (mixed-effects models, P = 0.04, P = 0.03, and P = 0.01, respectively). Post hoc pairwise comparisons revealed that electroacupuncture and minimal acupuncture were more efficacious than placebo acupuncture in ISI and PSQI at 1 week and 4 week post-treatment. Minimal acupuncture resulted in greater improvement in sleep diary-derived sleep efficiency than placebo acupuncture at 1 week post-treatment. There was no significant between-group difference in actigraphy measures, depressive symptoms, daily functioning, and hypnotic consumption, and no difference in any measures between electroacupuncture and minimal acupuncture.
Compared with placebo acupuncture, electroacupuncture and minimal acupuncture resulted in greater improvement in subjective sleep measures at 1 week and 4 week post-treatment. No significant difference was found between electroacupuncture and minimal acupuncture, suggesting that the observed differences could be due to nonspecific effects of needling, regardless of whether it is done according to traditional Chinese medicine theory.
评估电针对伴有重度抑郁症(MDD)的残留失眠的疗效和安全性。
随机、安慰剂对照。
精神科门诊。
78 名中国 DSM-IV 诊断为 MDD、失眠主诉、汉密尔顿抑郁量表(HDRS(17))评分≤18 且固定抗抑郁剂量的患者。
电针、微针(非穴位浅刺)或非侵入性安慰剂针灸每周 3 次,共 3 周。
在基线、治疗后 1 周和治疗后 4 周时进行失眠严重程度指数(ISI)、匹兹堡睡眠质量指数(PSQI)、HDRS(17)、1 周睡眠日记和 3 天活动记录仪测量。混合效应模型显示 ISI、PSQI 和睡眠日记衍生的睡眠效率存在显著的组间时间交互作用(P=0.04、P=0.03 和 P=0.01)。事后两两比较显示,电针和微针在治疗后 1 周和 4 周时在 ISI 和 PSQI 上比安慰剂针灸更有效。微针在治疗后 1 周时比安慰剂针灸更能改善睡眠日记衍生的睡眠效率。在活动记录仪测量、抑郁症状、日常功能和催眠药物使用方面,组间无显著差异,电针和微针之间也无差异。
与安慰剂针灸相比,电针和微针在治疗后 1 周和 4 周时主观睡眠测量有更大的改善。电针和微针之间没有发现显著差异,这表明观察到的差异可能是由于针刺的非特异性作用,而与是否根据中医理论进行针刺无关。